SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Argos Therapeutics, Inc. (ARGS)

ARGS RSS Feed
Add ARGS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/24/2017 1:20:49 PM - Followers: 22 - Board type: Free - Posts Today: 0

Argos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its products include AGS-003, which is under Phase III clinical trials and intended for the treatment of metastatic renal cell carcinoma (clear cell); and AGS-004, which is under Phase IIb clinical trials and is intended for the treatment of Human Immunodeficiency Virus. The company also develops AGS-003 for metastatic renal cell carcinoma (non-clear cell), early stage RCC, and other solid tumors. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is headquartered in Durham, North Carolina.(yahoo)
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARGS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ARGS News: Current Report Filing (8-k) 02/22/2017 08:06:11 AM
ARGS News: Independent Data Monitoring Committee Recommends Discontinuation of the ADAPT Phase 3 Clinical Trial of Rocapuldencel-T in Me... 02/22/2017 08:00:00 AM
ARGS News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 03:30:44 PM
ARGS News: Amended Statement of Ownership (sc 13g/a) 02/13/2017 05:09:10 PM
ARGS News: Argos Therapeutics to Participate in 2017 Genitourinary Cancers Symposium 02/13/2017 08:30:00 AM
PostSubject
#225   Is BK coming? They have more cash than Jiminy Cricket 02/24/17 01:20:49 PM
#224   Any hope for this one or is it Pip611 02/24/17 01:14:15 PM
#223   Biotech Movers And Shakers: Ocular Therapeutix Inc and trendmkr 02/23/17 02:01:37 PM
#222   Can somebody explain what's the trick? In phase Oren1976 02/23/17 01:25:46 AM
#221   HIV drug that just got discontinued yikes read 8k xfrozenx 02/22/17 07:06:53 PM
#220   hi :) does this company have any another kei 02/22/17 06:51:44 PM
#219   * * $ARGS Video Chart 02-22-17 * * ClayTrader 02/22/17 05:16:12 PM
#218   Bounce play? Overreaction imo Dr_Thorfin 02/22/17 09:50:36 AM
#217   time to buy more and average down Pip611 02/22/17 08:53:27 AM
#216   Thankfully not in this but look at the colmar 02/22/17 08:33:44 AM
#215   $ARGS cash net of debt as of YE davidsson10 02/22/17 08:25:12 AM
#214   ouch colmar 02/22/17 08:21:14 AM
#213   Better to be both instinctive; lucky/right:DMC says 75% FUTILITY maverick_1 02/22/17 08:18:30 AM
#212   It's easy to announce a continue, harder to flipper44 02/21/17 05:56:31 PM
#211   How did argos ensure that placebo attrition did Extremist223 02/21/17 03:35:34 PM
#210   Or not, just more shake down Extremist223 02/21/17 02:59:47 PM
#209   Maybe we will get the IDMC recommendation PR Pip611 02/19/17 06:36:41 PM
#208   Any ideas what was in the presentations from TiltMyBrain 02/19/17 05:41:18 PM
#207   They were scheduled to speak this morning I Extremist223 02/18/17 07:17:14 PM
#206   Does anyone know if Argos presented yet? Pip611 02/18/17 02:34:53 PM
#204   Looks like we're going into the weekend with Pip611 02/17/17 05:12:59 PM
#203   Where's the news! Let's go Argos! Pip611 02/17/17 06:18:15 AM
#202   Stock is trading in it's normal range, between austinmediainc 02/16/17 02:35:57 PM
#201   Yes, again I'm not invested, but I hoped flipper44 02/16/17 01:51:08 PM
#200   so much for our PR today Pip611 02/16/17 01:44:35 PM
#199   so much for our PR today Pip611 02/16/17 01:44:35 PM
#198   That is what I was expecting but notice 1hb 02/15/17 07:08:47 PM
#197   I will be watching this closely! Good news TiltMyBrain 02/14/17 04:09:39 PM
#196   Thursday morning or Friday evening, imo. I flipper44 02/14/17 02:34:15 PM
#195   flipper44 02/14/17 02:32:46 PM
#194   I bet we get a PR before market Pip611 02/14/17 02:13:07 PM
#193   I do not invest in this company, but flipper44 02/14/17 01:47:40 PM
#192   Will we get phase 3 update this Saturday? TiltMyBrain 02/13/17 11:34:02 AM
#191   The company is supposed to deliver an update Pip611 02/12/17 05:33:18 PM
#190   hello, am new to the board. althegambler 02/11/17 02:08:24 PM
#189   Interesting SA interview H2R 02/06/17 02:32:08 PM
#188   I'll wait for the Feb read-out before investing. H2R 02/03/17 12:15:22 PM
#187   Does anyone know if the clinicaltrials.gov changes made flipper44 02/01/17 02:41:13 PM
#186   Glad I didn't buy options. I never bank Pip611 01/31/17 07:14:30 AM
#185   Hi Koman, I can't private message but if austinmediainc 01/27/17 05:33:14 PM
#184   Hey Austin, Did the ARGS management talk about koman 01/26/17 10:25:32 AM
#183   Thanks Austin, H2R 01/25/17 03:22:01 PM
#182   He is an admitted short, and his information austinmediainc 01/25/17 02:41:22 PM
#181   What do you guys think of the following H2R 01/20/17 11:35:19 PM
#180   Hi Board, H2R 01/20/17 06:18:42 PM
#179   Based on the enrollment and other timelines they austinmediainc 01/19/17 02:45:20 PM
#178   Do we have data coming soon? Pip611 01/19/17 07:34:15 AM
#177   CTOs are common- and necessary- in biotech. If blackcat 12/19/16 12:45:17 PM
#176   I don't like secrets TiltMyBrain 12/19/16 12:12:54 PM
#175   It's not the shareholders they want to keep blackcat 12/19/16 11:48:33 AM
PostSubject